Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

ClinicalTrials.gov ID: NCT01098539

Public ClinicalTrials.gov record NCT01098539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 10:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment

Study identification

NCT ID
NCT01098539
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
507 participants

Conditions and interventions

Interventions

  • albiglutide Biological
  • sitagliptin Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Oct 31, 2012
Completion
Oct 31, 2012
Last update posted
Feb 27, 2017

2010 – 2012

United States locations

U.S. sites
121
U.S. states
30
U.S. cities
100
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35294
GSK Investigational Site Gulf Shores Alabama 36542
GSK Investigational Site Huntsville Alabama 35801
GSK Investigational Site Toney Alabama 35773
GSK Investigational Site Phoenix Arizona 85028
GSK Investigational Site Fresno California 93720
GSK Investigational Site Huntington Beach California 92648
GSK Investigational Site Los Angeles California 90017
GSK Investigational Site Los Angeles California 90022
GSK Investigational Site Los Angeles California 90073
GSK Investigational Site Los Gatos California 95032
GSK Investigational Site Orange California 92868
GSK Investigational Site San Diego California 92120
GSK Investigational Site San Diego California 92161
GSK Investigational Site San Dimas California 91773
GSK Investigational Site Tarzana California 91356
GSK Investigational Site West Hills California 91307
GSK Investigational Site Whittier California 90602
GSK Investigational Site Whittier California 90603
GSK Investigational Site Doral Florida 33172
GSK Investigational Site Hollywood Florida 33021
GSK Investigational Site Jacksonville Florida 32205
GSK Investigational Site Miami Florida 33136
GSK Investigational Site Miami Beach Florida 33141
GSK Investigational Site New Port Richey Florida 34653
GSK Investigational Site Pembroke Pines Florida 33028
GSK Investigational Site Plantation Florida 33322
GSK Investigational Site Tampa Florida 33613
GSK Investigational Site Winter Park Florida 32789
GSK Investigational Site Winter Park Florida 32792
GSK Investigational Site Atlanta Georgia 30312
GSK Investigational Site Atlanta Georgia 30342
GSK Investigational Site Augusta Georgia 30909
GSK Investigational Site Blue Ridge Georgia 30513
GSK Investigational Site Decatur Georgia 30032
GSK Investigational Site Roswell Georgia 30076
GSK Investigational Site Stone Mountain Georgia 30088
GSK Investigational Site Valparaiso Indiana 46383
GSK Investigational Site Des Moines Iowa 50314
GSK Investigational Site Mission Kansas 66202
GSK Investigational Site Lexington Kentucky 40504
GSK Investigational Site Paducah Kentucky 42003
GSK Investigational Site Alexandria Louisiana 71301
GSK Investigational Site Bangor Maine 04401
GSK Investigational Site Hyattsville Maryland 20782
GSK Investigational Site Springfield Massachusetts 01107
GSK Investigational Site Dearborn Michigan 48124
GSK Investigational Site Detroit Michigan 48235
GSK Investigational Site Flint Michigan 48504
GSK Investigational Site Saint Clair Shores Michigan 48081
GSK Investigational Site Taylor Michigan 48180
GSK Investigational Site Kansas City Missouri 64111
GSK Investigational Site Kansas City Missouri 64128
GSK Investigational Site Springfield Missouri 65807
GSK Investigational Site Omaha Nebraska 68131
GSK Investigational Site Las Vegas Nevada 89102
GSK Investigational Site Las Vegas Nevada 89103
GSK Investigational Site North Massapequa New York 11758
GSK Investigational Site Staten Island New York 10301
GSK Investigational Site Asheville North Carolina 28801
GSK Investigational Site Hurst North Carolina 76054
GSK Investigational Site Shelby North Carolina 28150
GSK Investigational Site Tabor City North Carolina 28463
GSK Investigational Site Wilmington North Carolina 28401
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Cincinnati Ohio 45219
GSK Investigational Site Cleveland Ohio 44195
GSK Investigational Site Gallipolis Ohio 45631
GSK Investigational Site Oklahoma City Oklahoma 73103
GSK Investigational Site Medford Oregon 97501
GSK Investigational Site Altoona Pennsylvania 16602
GSK Investigational Site Downington Pennsylvania 19335
GSK Investigational Site Philadelphia Pennsylvania 19146
GSK Investigational Site Charleston South Carolina 29412
GSK Investigational Site Columbia South Carolina 29204
GSK Investigational Site Greer South Carolina 29651
GSK Investigational Site North Myrtle Beach South Carolina 29582
GSK Investigational Site Taylors South Carolina 29687
GSK Investigational Site Bristol Tennessee 37620
GSK Investigational Site Franklin Tennessee 37067
GSK Investigational Site Knoxville Tennessee 37923
GSK Investigational Site Tullahoma Tennessee 37398
GSK Investigational Site Arlington Texas 76011
GSK Investigational Site Arlington Texas 76014
GSK Investigational Site Austin Texas 78751
GSK Investigational Site Austin Texas 78758
GSK Investigational Site Dallas Texas 75224
GSK Investigational Site Dallas Texas 75231
GSK Investigational Site Dallas Texas 75251
GSK Investigational Site Deer Park Texas 77536
GSK Investigational Site Fort Worth Texas 76104
GSK Investigational Site Grapevine Texas 76051
GSK Investigational Site Houston Texas 77027
GSK Investigational Site Houston Texas 77030
GSK Investigational Site Houston Texas 77036
GSK Investigational Site Houston Texas 77070
GSK Investigational Site Houston Texas 77074
GSK Investigational Site Houston Texas 77081
GSK Investigational Site Houston Texas 77088
GSK Investigational Site Houston Texas 77099
GSK Investigational Site Humble Texas 77338
GSK Investigational Site Hurst Texas 76054
GSK Investigational Site Irving Texas 75039
GSK Investigational Site Midland Texas 79707
GSK Investigational Site North Richland Hills Texas 76180
GSK Investigational Site Pearland Texas 77584
GSK Investigational Site Plano Texas 75075
GSK Investigational Site Richardson Texas 75080
GSK Investigational Site San Antonio Texas 78215
GSK Investigational Site San Antonio Texas 78217
GSK Investigational Site San Antonio Texas 78258
GSK Investigational Site Schertz Texas 78154
GSK Investigational Site Sugarland Texas 77479
GSK Investigational Site Tomball Texas 77375
GSK Investigational Site Bountiful Utah 84010
GSK Investigational Site South Burlington Vermont 05403
GSK Investigational Site Burke Virginia 22015
GSK Investigational Site Manassas Virginia 20110
GSK Investigational Site Norfolk Virginia 23510
GSK Investigational Site Salem Virginia 24153
GSK Investigational Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01098539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01098539 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →